Webinar | December 27, 2018

Immuno-Gene Therapeutics In Hematological Cancers: How Science Drives Study Strategy

This webinar reviews the current state of technology in gene therapeutics and examines trends in immuno-oncology and gene therapy for hematological malignancies. Topics include:

  • Ingredients for successful study planning and delivery
  • Operationalizing studies to achieve conclusive data outcomes
  • Data-driven approach to choosing the right sites in the right countries
  • Key drivers to retaining patients and meeting study endpoints
  • Exploring future trajectories in outsourcing models for innovative biotech companies

Speakers: Luke Gill, Executive Director, Oncology, Strategic Development, Premier Research and Colin Hayward, Chief Medical Officer, Premier Research

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: